Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts

Table of Contents

March 05, 2002; Volume 166,Issue 5

Highlights of this issue

  • You have access
    Highlights of this issue
    CMAJ March 05, 2002 166 (5) 577;

Editorial

  • You have access
    The better-than-nothing idea: debating the use of placebo controls
    CMAJ March 05, 2002 166 (5) 573;

Commentary

  • You have access
    Does PSA screening reduce prostate cancer mortality?
    André N. Vis
    CMAJ March 05, 2002 166 (5) 600-601;
  • You have access
    Hats off (or not?) to helmet legislation
    Mary L. Chipman
    CMAJ March 05, 2002 166 (5) 602;
  • You have access
    Placebo trials and tribulations
    Charles Weijer
    CMAJ March 05, 2002 166 (5) 603-604;

News

  • You have access
    Anne McLellan: new direction from a new minister?
    Charlotte Gray
    CMAJ March 05, 2002 166 (5) 639;
  • You have access
    “No statute remains frozen in time forever”: Romanow
    Wayne Kondro
    CMAJ March 05, 2002 166 (5) 640;
  • You have access
    Quebec puts smart-card technology on health care back burner
    Susan Pinker
    CMAJ March 05, 2002 166 (5) 640-640-a;
  • You have access
    Canada to reconsider ethics of placebo-controlled trials
    Barbara Sibbald
    CMAJ March 05, 2002 166 (5) 641;
  • You have access
    Sleep position can affect shape of babies' heads, hospital warns
    Janis Hass
    CMAJ March 05, 2002 166 (5) 641-641-a;
  • You have access
    High cost, poor food selection place northern women at nutritional risk
    Janis Hass
    CMAJ March 05, 2002 166 (5) 642;
  • You have access
    Obesity may soon be leading cause of preventable death in US
    Barbara Sibbald
    CMAJ March 05, 2002 166 (5) 642-642-a;
  • You have access
    Ottawa's GM food plan faces criticism
    Janis Hass
    CMAJ March 05, 2002 166 (5) 643;
  • You have access
    New “Daytox” centre opens for subgroup of Vancouver drug/alcohol addicts
    Heather Kent
    CMAJ March 05, 2002 166 (5) 643-643-a;
  • You have access
    Court's ultrasound ruling worries Canadian MDs
    Barbara Sibbald
    CMAJ March 05, 2002 166 (5) 643-643-b;
  • You have access
    Speed up drug-approval process, feds told
    Wayne Kondro
    CMAJ March 05, 2002 166 (5) 644;
  • You have access
    Children and the environment
    Barbara Sibbald
    CMAJ March 05, 2002 166 (5) 644-644-a;
  • You have access
    Ontario hosts roundtable on genetics and gene patenting
    Don Willison
    CMAJ March 05, 2002 166 (5) 645;
  • You have access
    In Iran, gender segregation becoming a fact of medical life
    Pejman Azarmina
    CMAJ March 05, 2002 166 (5) 645-645-a;
  • You have access
    MDs move from old liquor store to new clinic built by NS residents
    Donalee Moulton
    CMAJ March 05, 2002 166 (5) 646;
  • You have access
    Fewer Canadians have their own doctor
    Shelley Martin
    CMAJ March 05, 2002 166 (5) 646-646-a;
  • You have access
    Let the games begin
    Donalee Moulton
    CMAJ March 05, 2002 166 (5) 647;
  • You have access
    Tuition fees continue to rise
    Patrick Sullivan
    CMAJ March 05, 2002 166 (5) 647-647-a;

Research

  • You have access
    PSA screening and prostate cancer mortality
    Linda Perron, Lynne Moore, Isabelle Bairati, Paul-Marie Bernard and François Meyer
    CMAJ March 05, 2002 166 (5) 586-591;
  • You have access
    Effect of legislation on the use of bicycle helmets
    John C. LeBlanc, Tricia L. Beattie and Christopher Culligan
    CMAJ March 05, 2002 166 (5) 592-595;
  • You have access
    Cervical intraepithelial neoplasia in women presenting with external genital warts
    Michelle Howard, John Sellors and Alice Lytwyn
    CMAJ March 05, 2002 166 (5) 598-599;

Review

  • You have access
    Clinical nutrition: 4. Omega-3 fatty acids in cardiovascular care
    Bruce J. Holub
    CMAJ March 05, 2002 166 (5) 608-615;
  • You have access
    Advances in the pharmacotherapy of Alzheimer's disease
    Serge Gauthier
    CMAJ March 05, 2002 166 (5) 616-623;

Practice

  • You have access
    Osteoarticular tuberculosis: a case report and discussion
    Kira Payne and Jae Yang
    CMAJ March 05, 2002 166 (5) 628-630;
  • You have access
    Varicella control and vaccine coverage: issues and challenges
    Tamara Wallington and Erica Weir
    CMAJ March 05, 2002 166 (5) 631-632;
  • You have access
    Generalized peritonitis
    H.D. Hildebrand
    CMAJ March 05, 2002 166 (5) 632;
  • You have access
    Ephedra/ephedrine: cardiovascular and CNS effects
    Eric Wooltorton and Barbara Sibbald
    CMAJ March 05, 2002 166 (5) 633;

Letters

  • You have access
    Community health programs in Canada
    W. Harding Le Riche
    CMAJ March 05, 2002 166 (5) 579;
  • You have access
    Ethics and industry-sponsored research
    S.R. Loschiavo
    CMAJ March 05, 2002 166 (5) 579-579-a;
  • You have access
    Ethics and industry-sponsored research
    Chris Kuebler, Walter S. Nimmo, Joseph H. von Rickenbach, Dennis Gillings, Allan T. Morgan, Candace Kendle and Paul S. Covington
    CMAJ March 05, 2002 166 (5) 579-580;
  • You have access
    Ethics and industry-sponsored research
    Alan F. Holmer
    CMAJ March 05, 2002 166 (5) 580;
  • You have access
    Ethics and industry-sponsored research
    Olli S. Miettinen
    CMAJ March 05, 2002 166 (5) 580-581;
  • You have access
    Ethics and industry-sponsored research
    Barry Koehler
    CMAJ March 05, 2002 166 (5) 581;
  • You have access
    Ethics and industry-sponsored research
    Joseph L. Pater, Wendy Parulekar, Christopher O'Callagham, Lois Shepherd, Elizabeth Eisenhauer, Lesley Seymour, Dongsheng Tu and Keyue Ding
    CMAJ March 05, 2002 166 (5) 581-582;
  • You have access
    Ethics and industry-sponsored research
    Steven Lewis
    CMAJ March 05, 2002 166 (5) 582;
  • You have access
    Ethics and industry-sponsored research
    CMAJ March 05, 2002 166 (5) 582-582-a;

The Left Atrium

  • You have access
    The Oslerian impulse
    Lara Hazelton
    CMAJ March 05, 2002 166 (5) 634-635;
  • You have access
    To Sadie, from her sister Emily
    CMAJ March 05, 2002 166 (5) 635;
  • You have access
    Bravest face forward
    Jonah Samson
    CMAJ March 05, 2002 166 (5) 635-636;
  • You have access
    Tobacco for distempers
    Daniel Defoe
    CMAJ March 05, 2002 166 (5) 636;
  • You have access
    Atlas nodded
    Stephen Workman
    CMAJ March 05, 2002 166 (5) 637;
  • You have access
    Tobacco is like love
    Tobias Hume
    CMAJ March 05, 2002 166 (5) 637-637-a;

Deaths

  • You have access
    Deaths
    CMAJ March 05, 2002 166 (5) 696;

Éditorial

  • You have access
    Débat sur l'utilisation des placebos contrôlés
    CMAJ March 05, 2002 166 (5) 575;
Back to top
PreviousNext

In this issue

CMAJ
Vol. 166, Issue 5
5 Mar 2002
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • Highlights of this issue
  • Editorial
  • Commentary
  • News
  • Research
  • Review
  • Practice
  • Letters
  • The Left Atrium
  • Deaths
  • Éditorial
  • Most Read
  • Most Cited
  • Responses
Loading
  • The evolution of SARS-CoV-2 seroprevalence in Canada: a time-series study, 2020–2023
  • Diagnosis and management of toxicity associated with the recreational use of nitrous oxide
  • Lead toxicity from Ayurvedic medicines
  • Obesity in adults: a clinical practice guideline
  • Pelvic organ prolapse
More...

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire